Immunological Properties of Inulin-Type Fructans

Critical Reviews in Food Science and Nutrition

Volumn 55, Issue 3, 2015, Pages 414-436

  Vogt, Leonie ^a   Meyer, Diederick ^b   Pullens, Gerdie ^c   Faas, Marijke ^a   Smelt, Maaike ^a   Venema, Koen ^d   Ramasamy, Uttara ^e   Schols, Henk A ^e   De Vos, Paul ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Sensus   (Netherlands)

^c Cosun Food Technology Centre ^*  (Netherlands)

^d TNO   (Netherlands)

^e WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

fructooligosaccharide; gut associated lymphoid tissue; immunology; Inulin type fructans; oligofructose; prebiotics

Indexed keywords

FRUCTAN; INULIN;

CYTOLOGY; DENDRITIC CELL; DIET THERAPY; DRUG EFFECTS; FERMENTATION; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATION; INTESTINE MUCOSA; LACTOBACILLALES; METABOLISM;

DENDRITIC CELLS; FERMENTATION; FRUCTANS; HUMANS; IMMUNOMODULATION; INFLAMMATION; INTESTINAL MUCOSA; INULIN; LACTOBACILLALES;

EID: 84914162622     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2012.656772     Document Type: Article

References (230)

1. Abe, C., Fujita, K., Kikuchi, E., Hirano, S., Kuboki, H., Yamashita, A., Hashimoto, H., Mori, S. and Okada, M. (2004). Effects of alpha-linked galactooligosaccharide on adjuvant-induced arthritis in Wistar rats and type II collagen-induced arthritis in DBA/1J mice. Int. J. Tissue React. 26:65–73.
2. Abreu, M.T. (2010). Toll-like receptor signalling in the intestinal epithelium: How bacterial recognition shapes intestinal function. Nat. Rev. Immunol. 10:131–144.
3. Adib-Conquy, M., Moine, P., Asehnoune, K., Edouard, A., Espevik, T., Miyake, K., Werts, C. and Cavaillon, J.M. (2003). Toll-like receptor-mediated tumor necrosis factor and interleukin-10 production differ during systemic inflammation. Am. J. Respir. Crit. Care. Med. 168:158–164.
4. Adogony, V., Respondek, F., Biourge, V., Rudeaux, F., Delaval, J., BinAdogony, V., Respondek, F., Biourge, V., Rudeaux, F., Delaval, J., Bind, J. L., and Salmon, H. (2007). Effects of dietary scFOS on immunoglobulins in colostrums and milk of bitches. J Anim Physiol Anim Nutr (Berl). 91:169–174.
5. Albers, R., Antoine, J.M., Bourdet-Sicard, R., Calder, P.C., Gleeson, M., Lesourd, B., Samartin, S., Sanderson, I.R., Van Loo, J., Vas Dias, F.W. and Watzl, B. (2005). Markers to measure immunomodulation in human nutrition intervention studies. Br. J. Nutr. 94:452–481.
6. Alles, M.S., de Roos, N.M., Bakx, J.C., van de Lisdonk, E., Zock, P.L. and Hautvast, G.A. (1999). Consumption of fructooligosaccharides does not favorably affect blood glucose and serum lipid concentrations in patients with type 2 diabetes. Am. J. Clin. Nutr. 69:64–69.
7. Alles, M.S., Hautvast, J.G., Nagengast, F.M., Hartemink, R., Van Laere, K.M. and Jansen, J.B. (1996). Fate of fructo-oligosaccharides in the human intestine. Br. J. Nutr. 76:211–221.
8. Amati, L., Marzulli, G., Martulli, M., Pugliese, V., Caruso, C., Candore, G., Vasto, S. and Jirillo, E. (2010). Administration of a synbiotic to free-living elderly and evaluation of serum cytokines. A pilot study. Curr. Pharm. Des. 16:854–858.
9. Apanavicius, C.J., Powell, K.L., Vester, B.M., Karr-Lilienthal, L.K., Pope, L.L., Fastinger, N.D., Wallig, M.A., Tappenden, K.A. and Swanson, K.S. (2007). Fructan supplementation and infection affect food intake, fever, and epithelial sloughing from Salmonella challenge in weanling puppies. J. Nutr. 137:1923–1930.
10. Arslanoglu, S., Moro, G.E. and Boehm, G. (2007). Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life. J. Nutr. 137:2420–2424.
11. Arslanoglu, S., Moro, G.E., Schmitt, J., Tandoi, L., Rizzardi, S. and Boehm, G. (2008). Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J. Nutr. 138:1091–1095.
12. Astegiano, M., Pellicano, R., Terzi, E., Simondi, D. and Rizzetto, M. (2006). Treatment of irritable bowel syndrome. A case control experience. Minerva. Gastroenterol. Dietol. 52:359–363.
13. Bakke-McKellep, A. M., Penn, M. H., Salas, P. M., Refstie, S., Sperstad, S., Landsverk, T., Ringo, E., and Krogdahl, A. (2007). Effects of dietary soyabean meal, inulin and oxytetracycline on intestinal microbiota and epithelial cell stress, apoptosis and proliferation in the teleost Atlantic salmon (Salmo salar L.). Br J Nutr. 97:699–713.
14. Bakker-Zierikzee, A.M., Tol, E.A., Kroes, H., Alles, M.S., Kok, F.J. and Bindels, J.G. (2006). Faecal SIgA secretion in infants fed on pre- or probiotic infant formula. Pediatr. Allergy Immunol. 17:134–140.
15. Benyacoub, J., Rochat, F., Saudan, K.Y., Rochat, I., Antille, N., Cherbut, C., von der Weid, T., Schiffrin, E.J. and Blum, S. (2008). Feeding a diet containing a fructooligosaccharide mix can enhance Salmonella vaccine efficacy in mice. J. Nutr. 138:123–129.
16. Bolognani, F., Rumney, C.J., Pool-Zobel, B.L. and Rowland, I.R. (2001). Effect of lactobacilli, bifidobacteria and inulin on the formation of aberrant crypt foci in rats. Eur. J. Nutr. 40:293–300.
17. Bouhnik, Y., Achour, L., Paineau, D., Riottot, M., Attar, A. and Bornet, F. (2007). Four-week short chain fructo-oligosaccharides ingestion leads to increasing fecal bifidobacteria and cholesterol excretion in healthy elderly volunteers. Nutr. J. 6
18. Bouhnik, Y., Flourie, B., Riottot, M., Bisetti, N., Gailing, M.F., Guibert, A., Bornet, F. and Rambaud, J.C. (1996). Effects of fructo-oligosaccharides ingestion on fecal bifidobacteria and selected metabolic indexes of colon carcinogenesis in healthy humans. Nutr. Cancer. 26:21–29.
19. Bouhnik, Y., Raskine, L., Simoneau, G., Paineau, D. and Bornet, F. (2006). The capacity of short-chain fructo-oligosaccharides to stimulate faecal bifidobacteria: A dose-response relationship study in healthy humans. Nutr J. 5:8.
20. Bouhnik, Y., Vahedi, K., Achour, L., Attar, A., Salfati, J., Pochart, P., Marteau, P., Flourie, B., Bornet, F. and Rambaud, J.C. (1999). Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans. J. Nutr. 129:113–116.
21. Boutron-Ruault, M.C., Marteau, P., Lavergne-Slove, A., Myara, A., Gerhardt, M.F., Franchisseur, C., Bornet, F. and Eripolyp Study Group. (2005). Effects of a 3-mo consumption of short-chain fructo-oligosaccharides on parameters of colorectal carcinogenesis in patients with or without small or large colorectal adenomas. Nutr. Cancer. 53:160–168.
22. Brandtzaeg, P. and Johansen, F.E. (2005). Mucosal B cells: Phenotypic characteristics, transcriptional regulation, and homing properties. Immunol. Rev. 206:32–63.
23. Brown, A.J., Goldsworthy, S.M., Barnes, A.A., Eilert, M.M., Tcheang, L., Daniels, D., Muir, A.I., Wigglesworth, M.J., Kinghorn, I., Fraser, N.J., Pike, N.B., Strum, J.C., Steplewski, K.M., Murdock, P.R., Holder, J.C., Marshall, F.H., Szekeres, P.G., Wilson, S., Ignar, D.M., Foord, S.M., Wise, A. and Dowell, S.J. (2003). The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278:11312–11319.
24. Bruhwyler, J., Carreer, F., Demanet, E. and Jacobs, H. (2008). Digestive tolerance of inulin-type fructans: A double-blind, placebo-controlled, cross-over, dose-ranging, randomized study in healthy volunteers. Int. J. Food Sci. Nutr.:1–11.
25. Brunser, O., Gotteland, M., Cruchet, S., Figueroa, G., Garrido, D. and Steenhout, P. (2006). Effect of a milk formula with prebiotics on the intestinal microbiota of infants after an antibiotic treatment. Pediatr. Res. 59:451–456.
26. Buddington, K.K., Donahoo, J.B. and Buddington, R.K. (2002). Dietary oligofructose and inulin protect mice from enteric and systemic pathogens and tumor inducers. J. Nutr. 132:472–477.
27. Buddington, R.K., Williams, C.H., Chen, S.C. and Witherly, S.A. (1996). Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. Am. J. Clin. Nutr. 63:709–716.
28. Bunout, D., Hirsch, S., Pia de la Maza, M., Munoz, C., Haschke, F., Steenhout, P., Klassen, P., Barrera, G., Gattas, V. and Petermann, M. (2002). Effects of prebiotics on the immune response to vaccination in the elderly. JPEN J. Parenter Enteral. Nutr. 26:372–376.
29. Burns, A.J. and Rowland, I.R. (2004). Antigenotoxicity of probiotics and prebiotics on faecal water-induced DNA damage in human colon adenocarcinoma cells. Mutat. Res. 551:233–243.
30. Butel, M. J., Waligora-Dupriet, A. J., and Szylit, O. (2002). Oligofructose and experimental model of neonatal necrotising enterocolitis. Br J Nutr. 87 Suppl 2:S213–S219.
31. Carabin, I.G. and Flamm, W.G. (1999). Evaluation of safety of inulin and oligofructose as dietary fiber. Regul. Toxicol. Pharmacol. 30:268––282.
32. Casellas, F., Borruel, N., Torrejon, A., Varela, E., Antolin, M., Guarner, F. and Malagelada, J.R. (2007). Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin. Aliment. Pharmacol. Ther. 25:1061–1067.
33. Catala, I., Butel, M. J., Bensaada, M., Popot, F., Tessedre, A. C., Rimbault, A., and Szylit, O. (1999). Oligofructose contributes to the protective role of bifidobacteria in experimental necrotising enterocolitis in quails. J Med Microbiol. 48:89–94.
34. Cerezuela, R., Cuesta, A., Meseguer, J., and Angeles Esteban, M. (2008). Effects of inulin on gilthead seabream (Sparus aurata L.) innate immune parameters. Fish Shellfish Immunol. 24:663–668.
35. Chadwick, V.S., Chen, W.X., Shu, D.R., Paulus, B., Bethwaite, P., Tie, A. and Wilson, I. (2002). Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology. 122:1778-17791783.
36. Cherbut, C., Michel, C. and Lecannu, G. (2003). The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats. J. Nutr. 133:21–27.
37. Chermesh, I., Tamir, A., Reshef, R., Chowers, Y., Suissa, A., Katz, D., Gelber, M., Halpern, Z., Bengmark, S. and Eliakim, R. (2007). Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn's disease. Dig. Dis. Sci. 52:385–389.
38. Chieppa, M., Rescigno, M., Huang, A.Y. and Germain, R.N. (2006). Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. J. Exp. Med. 203:2841–2852.
39. Chin, R., Wang, J. and Fu, Y.X. (2003). Lymphoid microenvironment in the gut for immunoglobulin A and inflammation. Immunol. Rev. 195:190–201.
40. Clarke, G., Fitzgerald, P., Hennessy, A.A., Cassidy, E.M., Quigley, E.M., Ross, P., Stanton, C., Cryan, J.F. and Dinan, T.G. (2010). Marked elevations in pro-inflammatory polyunsaturated fatty acid metabolites in females with irritable bowel syndrome. J. Lipid. Res. 51:1186–1192.
41. Colecchia, A., Vestito, A., La Rocca, A., Pasqui, F., Nikiforaki, A., Festi, D. and Symbiotic Study Group. (2006). Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multicenter study. Minerva Gastroenterol. Dietol. 52:349–358.
42. Covington, D.K., Briscoe, C.A., Brown, A.J. and Jayawickreme, C.K. (2006). The G-protein-coupled receptor 40 family (GPR40-GPR43) and its role in nutrient sensing. Biochem. Soc. Trans. 34:770–773.
43. Crohn, B.B., Ginsberg, L. and Oppenheimer, G.D. (1932). Regional enteritis. A pathological and clinical entity. JAMA. 99:1323-13241329.
44. Cumberland, P., Sethi, D., Roderick, P.J., Wheeler, J.G., Cowden, J.M., Roberts, J.A., Rodrigues, L.C., Hudson, M.J., Tompkins, D.S. and IID Study Executive. (2003). The infectious intestinal disease study of England: A prospective evaluation of symptoms and health care use after an acute episode. Epidemiol. Infect. 130:453–460.
45. Cummings, J.H., Macfarlane, G.T. and Englyst, H.N. (2001). Prebiotic digestion and fermentation. Am. J. Clin. Nutr. 73:415S–420S.
46. Daddaoua, A., Puerta, V., Requena, P., Martinez-Ferez, A., Guadix, E., de Medina, F.S., Zarzuelo, A., Suarez, M.D., Boza, J.J. and Martinez-Augustin, O. (2006). Goat milk oligosaccharides are anti-inflammatory in rats with hapten-induced colitis. J. Nutr. 136:672–676.
47. de Kivit, S., Kraneveld, A.D., Garssen, J. and Willemsen, L.E. (2011). Glycan recognition at the interface of the intestinal immune system: Target for immune modulation via dietary components. Eur. J. Pharmacol.
48. Delzenne, N.M., Cani, P.D., Daubioul, C. and Neyrinck, A.M. (2005). Impact of inulin and oligofructose on gastrointestinal peptides. Br. J. Nutr. 93(Suppl 1):S157–61.
49. Delzenne, N.M., Cani, P.D. and Neyrinck, A.M. (2007). Modulation of glucagon-like peptide 1 and energy metabolism by inulin and oligofructose: Experimental data. J. Nutr. 137:2547S–2551S.
50. de Vrese, M. and Schrezenmeir, J. (2008). Probiotics, prebiotics, and synbiotics. Adv. Biochem. Eng. Biotechnol. 111:1–66.
51. Dinan, T.G., Cryan, J., Shanahan, F., Keeling, P.W. and Quigley, E.M. (2010). IBS: An epigenetic perspective. Nat. Rev. Gastroenterol. Hepatol. 7:465–471.
52. Dinan, T.G., Quigley, E.M., Ahmed, S.M., Scully, P., O’Brien, S., O’Mahony, L., O’Mahony, S., Shanahan, F. and Keeling, P.W. (2006). Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: Plasma cytokines as a potential biomarker? Gastroenterology. 130:304–311.
53. Duggan, C., Penny, M. E., Hibberd, P., Gil, A., Huapaya, A., Cooper, A., Coletta, F., Emenhiser, C., and Kleinman, R. E. (2003). Oligofructose-supplemented infant cereal: 2 randomized, blinded, community-based trials in Peruvian infants. Am J Clin Nutr. 77:937–942.
54. Dunlop, S.P., Jenkins, D., Neal, K.R. and Spiller, R.C. (2003). Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. 125:1651–1659.
55. Eiwegger, T., Stahl, B., Haidl, P., Schmitt, J., Boehm, G., Dehlink, E., Urbanek, R. and Szepfalusi, Z. (2010). Prebiotic oligosaccharides: in vitro evidence for gastrointestinal epithelial transfer and immunomodulatory properties. Pediatr. Allergy Immunol. 21:1179–1188.
56. Elinav, E., Strowig, T., Henao-Mejia, J. and Flavell, R.A. (2011). Regulation of the antimicrobial response by NLR proteins. Immunity. 34:665–679.
57. Femia, A.P., Luceri, C., Dolara, P., Giannini, A., Biggeri, A., Salvadori, M., Clune, Y., Collins, K.J., Paglierani, M. and Caderni, G. (2002). Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis. 23:1953–1960.
58. Figdor, C.G. and van Spriel, A.B. (2010). Fungal pattern-recognition receptors and tetraspanins: Partners on antigen-presenting cells. Trends Immunol. 31:91–96.
59. Forest, V., Pierre, F., Bassonga, E., Meflah, K. and Menanteau, J. (2005). Large intestine intraepithelial lymphocytes from Apc+/+ and Apc+/Min mice and their modulation by indigestible carbohydrates: The IL-15/IL-15R alpha complex and CD4+ CD25+ T cells are the main targets. Cancer Immunol. Immunother. 54:78–86.
60. Fujitani, S., Ueno, K., Kamiya, T., Tsukahara, T., Ishihara, K., Kitabayashi, T. and Itabashi, K. (2007). Increased number of CCR4-positive cells in the duodenum of ovalbumin-induced food allergy model Nc/jic mice and antiallergic activity of fructooligosaccharides. Allergol. Int. 56:131–138.
61. Furrie, E., Macfarlane, S., Kennedy, A., Cummings, J.H., Walsh, S.V., O’neil, D.A. and Macfarlane, G.T. (2005). Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: A randomised controlled pilot trial. Gut. 54:242–249.
62. Gibson, G.R., Beatty, E.R., Wang, X. and Cummings, J.H. (1995). Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology. 108:975–982.
63. Gibson, G.R. and Roberfroid, M.B. (1995). Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J. Nutr. 125:1401–1412.
64. Gomez-Conde, M.S., Garcia, J., Chamorro, S., Eiras, P., Rebollar, P.G., Perez de Rozas, A., Badiola, I., de Blas, C. and Carabano, R. (2007). Neutral detergent-soluble fiber improves gut barrier function in twenty-five-day-old weaned rabbits. J. Anim. Sci. 85:3313–3321.
65. Gruenwald, J., Busch, R. and Bentley, C. (2009). Efficacy and tolerability of Laxatan Granulat in patients with chronic constipation. Clin. Exp. Gastroenterol. 2:95–100.
66. Guigoz, Y., Rochat, F. and Perruisseau-Carrier, G. (2002). Effects of oligosaccharide on the faecal flora and nonspecific immunesystem in elderly people. Nutr. Res. 22:13-1425.
67. Guilliano, M.J., Foxx-Orenstein, A.E. and Lebman, D.A. (2001). The microenvironment of human Peyer's patches inhibits the increase in CD38 expression associated with the germinal center reaction. J. Immunol. 166:2179–2185.
68. Gwee, K.A., Leong, Y.L., Graham, C., McKendrick, M.W., Collins, S.M., Walters, S.J., Underwood, J.E. and Read, N.W. (1999). The role of psychological and biological factors in postinfective gut dysfunction. Gut. 44:400–406.
69. Halas, D., Hansen, C.F. and Hampson, D.J. (2009). Effect of dietary supplementation with inulin and/or benzoic acid on the incidence and severity of post-weaning diarrhoea in weaner pigs after experimental challenge with enterotoxigenic Escherichia coli. Arch. Anim. Nutr. 63:267-268280.
70. Hapfelmeier, S., Muller, A.J., Stecher, B., Kaiser, P., Barthel, M., Endt, K., Eberhard, M., Robbiani, R., Jacobi, C.A., Heikenwalder, M., Kirschning, C., Jung, S., Stallmach, T., Kremer, M. and Hardt, W.D. (2008). Microbe sampling by mucosal dendritic cells is a discrete, MyD88-independent step in DeltainvG S. Typhimurium colitis. J. Exp. Med. 205:437–450.
71. Harrington, L.E., Hatton, R.D., Mangan, P.R., Turner, H., Murphy, T.L., Murphy, K.M. and Weaver, C.T. (2005). Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6:1123–1132.
72. Harrington, L.E., Mangan, P.R. and Weaver, C.T. (2006). Expanding the effector CD4 T-cell repertoire: The Th17 lineage. Curr. Opin. Immunol. 18:349–356.
73. Hata, K. and oh, A., Sato, H., Araki, Y., Tanaka, M., Tsujikawa, T., Fujiyama, Y. and Bamba, T. (2001). Sequential changes in luminal microflora and mucosal cytokine expression during developing of colitis in HLA-B27/beta2-microglobulin transgenic rats. Scand. J. Gastroenterol. 36:1185–1192.
74. Heer, A.K., Shamshiev, A., Donda, A., Uematsu, S., Akira, S., Kopf, M. and Marsland, B.J. (2007). TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses. J. Immunol. 178:2182–2191.
75. Hijova, E., Chmelarova, A., Bomba, A. and Zitnan, R. (2009). Prebiotic foodstuffs and their health benefits in experiment. Bratisl. Lek Listy. 110:523–525.
76. Hoentjen, F., Welling, G.W., Harmsen, H.J., Zhang, X., Snart, J., Tannock, G.W., Lien, K., Churchill, T.A., Lupicki, M. and Dieleman, L.A. (2005). Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation. Inflamm. Bowel. Dis. 11:977–985.
77. Holma, R., Juvonen, P., Asmawi, M.Z., Vapaatalo, H. and Korpela, R. (2002). Galacto-oligosaccharides stimulate the growth of bifidobacteria but fail to attenuate inflammation in experimental colitis in rats. Scand J. Gastroenterol. 37:1042–1047.
78. Hooper, L.V. and Macpherson, A.J. (2010). Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat. Rev. Immunol. 10:159–169.
79. Hosono, A., Ozawa, A., Kato, R., Ohnishi, Y., Nakanishi, Y., Kimura, T. and Nakamura, R. (2003). Dietary fructooligosaccharides induce immunoregulation of intestinal IgA secretion by murine Peyer's patch cells. Biosci. Biotechnol. Biochem. 67:758–764.
80. Hughes, R. and Rowland, I.R. (2001). Stimulation of apoptosis by two prebiotic chicory fructans in the rat colon. Carcinogenesis. 22:43–47.
81. Hunter, J.O., Tuffnell, Q. and Lee, A.J. (1999). Controlled trial of oligofructose in the management of irritable bowel syndrome. J. Nutr. 129:1451
82. Ito, H., Tanabe, H., Kawagishi, H., Tadashi, W., Yasuhiko, T., Sugiyama, K., Kiriyama, S. and Morita, T. (2009). Short-chain inulin-like fructans reduce endotoxin and bacterial translocations and attenuate development of TNBS-induced colitis in rats. Dig. Dis. Sci. 54:2100–2108.
83. Janardhana, V., Broadway, M.M., Bruce, M.P., Lowenthal, J.W., Geier, M.S., Hughes, R.J. and Bean, A.G. (2009). Prebiotics modulate immune responses in the gut-associated lymphoid tissue of chickens. J. Nutr. 139:1404–1409.
84. Janeway, C.A., Jr. (1989). Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54(Pt 1):1–13.
85. Johansson, M. E., Ambort, D., Pelaseyed, T., Schutte, A., Gustafsson, J. K., Ermund, A., Subramani, D. B., Holmen-Larsson, J. M., Thomsson, K. A., Bergstrom, J. H., van der Post, S., Rodriguez-Pineiro, A. M., Sjovall, H., Backstrom, M., and Hansson, G. C. (2011). Composition and functional role of the mucus layers in the intestine. Cell Mol Life Sci. 77:937–942.
86. Kapiki, A., Costalos, C., Oikonomidou, C., Triantafyllidou, A., Loukatou, E. and Pertrohilou, V. (2007). The effect of a fructo-oligosaccharide supplemented formula on gut flora of preterm infants. Early Hum. Dev. 83:335–339.
87. Kaplan, H. and Hutkins, R.W. (2000). Fermentation of fructooligosaccharides by lactic acid bacteria and bifidobacteria. Appl. Environ. Microbiol. 66:2682–2684.
88. Karczewski, J., Troost, F.J., Konings, I., Dekker, J., Kleerebezem, M., Brummer, R.J. and Wells, J.M. (2010). Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am. J. Physiol. Gastrointest Liver Physiol. 298:G851–G859.
89. Kartheuser, A., West, S., Walon, C., Curtis, A., Hamzehloei, T., Lannoy, N., Michiels, G., Smaers, M., Chapman, P. and Burn, J. (1995). The genetic background of familial adenomatous polyposis. Linkage analysis, the APC gene identification and mutation screening. Acta. Gastroenterol. Belg. 58:433–451.
90. Kelly, G. (2008). Inulin-type prebiotics–a review: Part 1. Altern. Med. Rev. 13:315–329.
91. Kelly, G. (2009). Inulin-type prebiotics: A review. (Part 2). Altern. Med. Rev. 14:36–55.
92. Kelly-Quagliana, K.A., Nelson, P.D. and Buddington, R.K. (2003). Dietary oligofructose and inulin modulate immune functions in mice. Nutr. Res. 23:257-258267.
93. Kennedy, P.J., Clarke, G., Quigley, E.M., Groeger, J.A., Dinan, T.G. and Cryan, J.F. (2011). Gut memories: Towards a cognitive neurobiology of irritable bowel syndrome. Neurosci. Biobehav. Rev.
94. Kidd, P. (2003). Th1/Th2 balance: The hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev. 8:223–246.
95. Kim, S.H., Lee da, H. and Meyer, D. (2007). Supplementation of baby formula with native inulin has a prebiotic effect in formula-fed babies. Asia Pac. J. Clin. Nutr. 16:172–177.
96. Kleessen, B., Sykura, B., Zunft, H.J. and Blaut, M. (1997). Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. Am. J. Clin. Nutr. 65:1397–1402.
97. Klinder, A., Forster, A., Caderni, G., Femia, A.P. and Pool-Zobel, B.L. (2004). Fecal water genotoxicity is predictive of tumor-preventive activities by inulin-like oligofructoses, probiotics (Lactobacillus rhamnosus and Bifidobacterium lactis), and their synbiotic combination. Nutr. Cancer. 49:144–155.
98. Kolida, S., Tuohy, K. and Gibson, G.R. (2002). Prebiotic effects of inulin and oligofructose. Br. J. Nutr. 87(Suppl 2):S193–7.
99. Kurowska-Stolarska, M., Kewin, P., Murphy, G., Russo, R.C., Stolarski, B., Garcia, C.C., Komai-Koma, M., Pitman, N., Li, Y., Niedbala, W., McKenzie, A.N., Teixeira, M.M., Liew, F.Y. and Xu, D. (2008). IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J. Immunol. 181:4780–4790.
100. Langkamp-Henken, B., Bender, B.S., Gardner, E.M., Herrlinger-Garcia, K.A., Kelley, M.J., Murasko, D.M., Schaller, J.P., Stechmiller, J.K., Thomas, D.J. and Wood, S.M. (2004). Nutritional formula enhanced immune function and reduced days of symptoms of upper respiratory tract infection in seniors. J. Am. Geriatr. Soc. 52:3–12.
101. Langkamp-Henken, B., Wood, S.M., Herlinger-Garcia, K.A., Thomas, D.J., Stechmiller, J.K., Bender, B.S., Gardner, E.M., DeMichele, S.J., Schaller, J.P. and Murasko, D.M. (2006). Nutritional formula improved immune profiles of seniors living in nursing homes. J. Am. Geriatr. Soc. 54:1861–1870.
102. Langlands, S.J., Hopkins, M.J., Coleman, N. and Cummings, J.H. (2004). Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut. 53:1610–1616.
103. Lara-Villoslada, F., Debras, E., Nieto, A., Concha, A., Galvez, J., Lopez-Huertas, E., Boza, J., Obled, C. and Xaus, J. (2006). Oligosaccharides isolated from goat milk reduce intestinal inflammation in a rat model of dextran sodium sulfate-induced colitis. Clin. Nutr. 25:477–488.
104. Leenen, C.H. and Dieleman, L.A. (2007). Inulin and oligofructose in chronic inflammatory bowel disease. J. Nutr. 137:2572
105. Le Poul, E., Loison, C., Struyf, S., Springael, J.Y., Lannoy, V., Decobecq, M.E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., Parmentier, M. and Detheux, M. (2003). Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J. Biol. Chem. 278:25481–25489.
106. Liebregts, T., Adam, B., Bredack, C., Roth, A., Heinzel, S., Lester, S., Downie-Doyle, S., Smith, E., Drew, P., Talley, N.J. and Holtmann, G. (2007). Immune activation in patients with irritable bowel syndrome. Gastroenterology. 132:913–920.
107. Lindsay, J.O., Whelan, K., Stagg, A.J., Gobin, P., Al-Hassi, H.O., Rayment, N., Kamm, M.A., Knight, S.C. and Forbes, A. (2006). Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease. Gut. 55:348–355.
108. Lomax, A.R. and Calder, P.C. (2009). Probiotics, immune function, infection and inflammation: A review of the evidence from studies conducted in humans. Curr. Pharm. Des. 15:1428–1518.
109. Loo, Y.M. and Gale, M., Jr. (2011). Immune signaling by RIG-I-like receptors. Immunity. 34:680–692.
110. Lopez Roman, J., Martinez Gonzalvez, A.B., Luque, A., Pons Minano, J.A., Vargas Acosta, A., Iglesias, J.R., Hernandez, M. and Villegas, J.A. (2008). The effect of a fibre enriched dietary milk product in chronic primary idiopatic constipation. Nutr. Hosp. 23:12–19.
111. Lories, R.J. (2006). Animal models of spondyloarthritis. Curr. Opin. Rheumatol. 18:342–346.
112. Macfarlane, S., Furrie, E., Kennedy, A., Cummings, J.H. and Macfarlane, G.T. (2005). Mucosal bacteria in ulcerative colitis. Br. J. Nutr. 93(Suppl 1):S67–72.
113. Macfarlane, G.T. and Macfarlane, S. (2011). Fermentation in the human large intestine: Its physiologic consequences and the potential contribution of prebiotics. J. Clin. Gastroenterol. 45(Suppl):S120–S127.
114. Macfarlane, G.T., Steed, H. and Macfarlane, S. (2008). Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J. Appl. Microbiol. 104:305–344.
115. MacPherson, G., Milling, S., Yrlid, U., Cousins, L., Turnbull, E. and Huang, F.P. (2004). Uptake of antigens from the intestine by dendritic cells. Ann. NY Acad. Sci. 1029:75–82.
116. Manhart, N., Spittler, A., Bergmeister, H., Mittlbock, M., and Roth, E. (2003). Influence of fructooligosaccharides on Peyer's patch lymphocyte numbers in healthy and endotoxemic mice. Nutrition. 77:937–942.
117. Marteau, P., Jacobs, H., Cazaubiel, M., Signoret, C., Prevel, J.M. and Housez, B. (2011). Effects of chicory inulin in constipated elderly people: A double-blind controlled trial. Int. J. Food Sci. Nutr. 62:164–170.
118. Maslowski, K.M., Vieira, A.T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H.C., Rolph, M.S., Mackay, F., Artis, D., Xavier, R.J., Teixeira, M.M. and Mackay, C.R. (2009). Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 461:1282–1286.
119. McGlone, J.J. and Fullwood, S.D. (2001). Behavior, reproduction, and immunity of crated pregnant gilts: Effects of high dietary fiber and rearing environment. J. Anim. Sci. 79:1466–1474.
120. McKernan, D.P., Gaszner, G., Quigley, E.M., Cryan, J.F. and Dinan, T.G. (2011). Altered peripheral toll-like receptor responses in the irritable bowel syndrome. Aliment Pharmacol. Ther. 33:1045–1052.
121. McKernan, D.P., Nolan, A., Brint, E.K., O’Mahony, S.M., Hyland, N.P., Cryan, J.F. and Dinan, T.G. (2009). Toll-like receptor mRNA expression is selectively increased in the colonic mucosa of two animal models relevant to irritable bowel syndrome. PLoS One. 4:e8226.
122. Meijer, K., de Vos, P. and Priebe, M.G. (2010). Butyrate and other short-chain fatty acids as modulators of immunity: What relevance for health? Curr. Opin. Clin. Nutr. Metab. Care. 13:715–721.
123. Menne, E., Guggenbuhl, N. and Roberfroid, M. (2000). Fn-type chicory inulin hydrolysate has a prebiotic effect in humans. J. Nutr. 130:1197–1199.
124. Menrad, K. (2003). Market and marketing of functional food in Europe. J. Food Eng. 56:181-182188.
125. Middelbos, I.S., Fastinger, N.D. and Fahey, G.C. , Jr. (2007). Evaluation of fermentable oligosaccharides in diets fed to dogs in comparison to fiber standards. J. Anim. Sci. 85:3033–3044.
126. Milo, L. A., Correa-Matos, N. J., Donovan, S. M., and Tappenden, K. A. (2004). Neutrophil and small intestinal lymphocyte migration after Salmonella typhimurium infection: impact of fermentable fiber. J Pediatr Gastroenterol Nutr. 77:937–942.
127. Misikangas, M., Pajari, A.M., Paivarinta, E. and Mutanen, M. (2005). Promotion of adenoma growth by dietary inulin is associated with increase in cyclin D1 and decrease in adhesion proteins in Min/+ mice mucosa. J. Nutr. Biochem. 16:402–409.
128. Misikangas, M., Tanayama, H., Rajakangas, J., Linden, J., Pajari, A.M. and Mutanen, M. (2008). Inulin results in increased levels of beta-catenin and cyclin D1 as the adenomas increase in size from small to large in the Min/+ mouse. Br. J. Nutr. 99:963–970.
129. Mollet, B. and Rowland, I. (2002). Functional foods: At the frontier between food and pharma. Curr. Opin. Biotechnol. 13:483–485.
130. Moreau, N.M., Martin, L.J., Toquet, C.S., Laboisse, C.L., Nguyen, P.G., Siliart, B.S., Dumon, H.J. and Champ, M.M. (2003). Restoration of the integrity of rat caeco-colonic mucosa by resistant starch, but not by fructo-oligosaccharides, in dextran sulfate sodium-induced experimental colitis. Br. J. Nutr. 90:75–85.
131. Moro, G., Arslanoglu, S. and Stahl, B. (2006a). Infant formula supplemented with a prebiotic mixture of galacto-oligosaccharides and long chain fructo-oligosaccharides reduces the cumulative incidence of atopic dermatitis in infants at risk. J. Pediatr. Gastroenterol. Nutr. 42
132. Moro, G., Arslanoglu, S., Stahl, B., Jelinek, J., Wahn, U. and Boehm, G. (2006b). A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch. Dis. Child. 91:814–819.
133. Mowat, A.M. (2003). Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3:331–341.
134. Munjal, U., Glei, M., Pool-Zobel, B.L. and Scharlau, D. (2009). Fermentation products of inulin-type fructans reduce proliferation and induce apoptosis in human colon tumor cells of different stages of carcinogenesis. Br. J. Nutr. 102:663–671.
135. Murosaki, S., Muroyama, K., Yamamoto, Y., Kusaka, H., Liu, T. and Yoshikai, Y. (1999). Immunopotentiating activity of nigerooligosaccharides for the T helper 1-like immune response in mice. Biosci. Biotechnol. Biochem. 63:373–378.
136. Nakamura, Y., Nosaka, S., Suzuki, M., Nagafuchi, S., Takahashi, T., Yajima, T., Takenouchi-Ohkubo, N., Iwase, T. and Moro, I. (2004). Dietary fructooligosaccharides up-regulate immunoglobulin A response and polymeric immunoglobulin receptor expression in intestines of infant mice. Clin. Exp. Immunol. 137:52–58.
137. Neal, K.R., Hebden, J. and Spiller, R. (1997). Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: Postal survey of patients. BMJ. 314:779–782.
138. Newberry, R.D. and Lorenz, R.G. (2005). Organizing a mucosal defense. Immunol. Rev. 206:6–21.
139. Niess, J.H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B.A., Vyas, J.M., Boes, M., Ploegh, H.L., Fox, J.G., Littman, D.R. and Reinecker, H.C. (2005). CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science. 307:254–258.
140. Olesen, M. and Gudmand-Hoyer, E. (2000). Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. Am. J. Clin. Nutr. 72:1570–1575.
141. Olguin, F., Araya, M., Hirsch, S., Brunser, O., Ayala, V., Rivera, R. and Gotteland, M. (2005). Prebiotic ingestion does not improve gastrointestinal barrier function in burn patients. Burns. 31:482–488.
142. Osman, N., Adawi, D., Molin, G., Ahrne, S., Berggren, A. and Jeppsson, B. (2006). Bifidobacterium infantis strains with and without a combination of oligofructose and inulin (OFI) attenuate inflammation in DSS-induced colitis in rats. BMC Gastroenterol. 6:31.
143. Osorio, F. and Reis e Sousa, C. (2011). Myeloid C-type lectin receptors in pathogen recognition and host defense. Immunity. 34:651–664.
144. O’Malley, D., Liston, M., Hyland, N.P., Dinan, T.G. and Cryan, J.F. (2011). Colonic soluble mediators from the maternal separation model of irritable bowel syndrome activate submucosal neurons via an interleukin-6-dependent mechanism. Am. J. Physiol. Gastrointest. Liver Physiol. 300:G241–G252.
145. Paineau, D., Payen, F., Panserieu, S., Coulombier, G., Sobaszek, A., Lartigau, I., Brabet, M., Galmiche, J.P., Tripodi, D., Sacher-Huvelin, S., Chapalain, V., Zourabichvili, O., Respondek, F., Wagner, A. and Bornet, F.R. (2008). The effects of regular consumption of short-chain fructo-oligosaccharides on digestive comfort of subjects with minor functional bowel disorders. Br. J. Nutr. 99:311–318.
146. Pajari, A.M., Rajakangas, J., Paivarinta, E., Kosma, V.M., Rafter, J. and Mutanen, M. (2003). Promotion of intestinal tumor formation by inulin is associated with an accumulation of cytosolic beta-catenin in Min mice. Int. J. Cancer. 106:653–660.
147. Parnell, J.A. and Reimer, R.A. (2010). Effect of prebiotic fibre supplementation on hepatic gene expression and serum lipids: A dose-response study in JCR:LA-cp rats. Br. J. Nutr. 103:1577–1584.
148. Pasare, C. and Medzhitov, R. (2005). Control of B-cell responses by Toll-like receptors. Nature. 438:364–368.
149. Pedersen, A., Sandstrom, B. and Van Amelsvoort, J.M. (1997). The effect of ingestion of inulin on blood lipids and gastrointestinal symptoms in healthy females. Br. J. Nutr. 78:215–222.
150. Perez, N., Iannicelli, J.C., Girard-Bosch, C., Gonzalez, S., Varea, A., Disalvo, L., Apezteguia, M., Pernas, J., Vicentin, D. and Cravero, R. (2010). Effect of probiotic supplementation on immunoglobulins, isoagglutinins and antibody response in children of low socio-economic status. Eur. J. Nutr. 49:173–179.
151. Petkevicius, S., Bach Knudsen, K.E., Murrell, K.D. and Wachmann, H. (2003). The effect of inulin and sugar beet fibre on oesophagostomum dentatum infection in pigs. Parasitology. 127:61–68.
152. Petkevicius, S., Thomsen, L.E., Bach Knudsen, K.E., Murrell, K.D., Roepstorff, A. and Boes, J. (2007). The effect of inulin on new and on patent infections of Trichuris suis in growing pigs. Parasitology. 134:121–127.
153. Podolsky, D.K. (2002). Inflammatory bowel disease. N. Engl. J. Med. 347:417–429.
154. Pool-Zobel, B., van Loo, J., Rowland, I. and Roberfroid, M.B. (2002). Experimental evidences on the potential of prebiotic fructans to reduce the risk of colon cancer. Br. J. Nutr. 87(Suppl 2):S273–S281.
155. Poulsen, M., Molck, A.M. and Jacobsen, B.L. (2002). Different effects of short- and long-chained fructans on large intestinal physiology and carcinogen-induced aberrant crypt foci in rats. Nutr. Cancer. 42:194–205.
156. Raes, M., Scholtens, P.A., Alliet, P., Hensen, K., Jongen, H., Boehm, G., Vandenplas, Y. and Rummens, J.L. (2010). Exploration of basal immune parameters in healthy infants receiving an infant milk formula supplemented with prebiotics. Pediatr. Allergy Immunol. 21:e377–e385.
157. Rafter, J., Bennett, M., Caderni, G., Clune, Y., Hughes, R., Karlsson, P.C., Klinder, A., O’Riordan, M., O’Sullivan, G.C., Pool-Zobel, B., Rechkemmer, G., Roller, M., Rowland, I., Salvadori, M., Thijs, H., Van Loo, J., Watzl, B. and Collins, J.K. (2007). Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am. J. Clin. Nutr. 85:488–496.
158. Ramiro-Puig, E., Perez-Cano, F.J., Castellote, C., Franch, A. and Castell, M. (2008). The bowel: A key component of the immune system. Rev. Esp. Enferm. Dig. 100:29–34.
159. Rao, C.V., Chou, D., Simi, B., Ku, H. and Reddy, B.S. (1998). Prevention of colonic aberrant crypt foci and modulation of large bowel microbial activity by dietary coffee fiber, inulin and pectin. Carcinogenesis. 19:1815–1819.
160. Rath, H.C., Schultz, M., Freitag, R., Dieleman, L.A., Li, F., Linde, H.J., Scholmerich, J. and Sartor, R.B. (2001). Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun. 69:2277–2285.
161. Reddy, B.S. (1998). Prevention of colon cancer by pre- and probiotics: Evidence from laboratory studies. Br. J. Nutr. 80:S219–S223.
162. Reddy, B.S., Hamid, R. and Rao, C.V. (1997). Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis. 18:1371–1374.
163. Reddy, B.S., Macfie, J., Gatt, M., Larsen, C.N., Jensen, S.S. and Leser, T.D. (2007). Randomized clinical trial of effect of synbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy. Br. J. Surg. 94:546–554.
164. Rijnierse, A., Jeurink, P.V., Garssen, J. and Knippels, L.M. (2011). Food-derived oligosaccharides exhibit pharmaceutical properties. Eur. J. Pharmacol.
165. Roberfroid, M.B. (1999). Concepts in functional foods: The case of inulin and oligofructose. J. Nutr. 129:1398S–401S.
166. Roberfroid, M.B. (2005). Introducing inulin-type fructans. Br. J. Nutr. 93(Suppl 1):S13–25.
167. Roberfroid, M.B. (2007). Inulin-type fructans: Functional food ingredients. J. Nutr. 137:2493S–2502S.
168. Roberfroid, M., Gibson, G.R., Hoyles, L., McCartney, A.L., Rastall, R., Rowland, I., Wolvers, D., Watzl, B., Szajewska, H., Stahl, B., Guarner, F., Respondek, F., Whelan, K., Coxam, V., Davicco, M.J., Leotoing, L., Wittrant, Y., Delzenne, N.M., Cani, P.D., Neyrinck, A.M. and Meheust, A. (2010). Prebiotic effects: Metabolic and health benefits. Br. J. Nutr. 104(Suppl 2):S1–63.
169. Roller, M., Clune, Y., Collins, K., Rechkemmer, G. and Watzl, B. (2007). Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients. Br. J. Nutr. 97:676–684.
170. Roller, M., Pietro Femia, A., Caderni, G., Rechkemmer, G. and Watzl, B. (2004a). Intestinal immunity of rats with colon cancer is modulated by oligofructose-enriched inulin combined with Lactobacillus rhamnosus and Bifidobacterium lactis. Br. J. Nutr. 92:931–938.
171. Roller, M., Rechkemmer, G. and Watzl, B. (2004b). Prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis modulates intestinal immune functions in rats. J. Nutr. 134:153–156.
172. Rossi, M., Corradini, C., Amaretti, A., Nicolini, M., Pompei, A., Zanoni, S. and Matteuzzi, D. (2005). Fermentation of fructooligosaccharides and inulin by bifidobacteria: A comparative study of pure and fecal cultures. Appl. Environ. Microbiol. 71:6150–6158.
173. Rowland, I.R., Rumney, C.J., Coutts, J.T. and Lievense, L.C. (1998). Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis. 19:281–285.
174. Rumessen, J.J., Bode, S., Hamberg, O. and Gudmand-Hoyer, E. (1990). Fructans of Jerusalem artichokes: Intestinal transport, absorption, fermentation, and influence on blood glucose, insulin, and C-peptide responses in healthy subjects. Am. J. Clin. Nutr. 52:675–681.
175. Saavedra, J. M. and Tschernia, A. (2002). Human studies with probiotics and prebiotics: clinical implications. Br J Nutr. 87 Suppl 2:S241–S246
176. Sartor, R. B. (2004). Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology. 77:937–942.
177. Schiffrin, E.J., Thomas, D.R., Kumar, V.B., Brown, C., Hager, C., Van't Hof, M.A., Morley, J.E. and Guigoz, Y. (2007). Systemic inflammatory markers in older persons: The effect of oral nutritional supplementation with prebiotics. J. Nutr. Health Aging. 11:475–479.
178. Scholtens, P.A., Alliet, P., Raes, M., Alles, M.S., Kroes, H., Boehm, G., Knippels, L.M., Knol, J. and Vandenplas, Y. (2008). Fecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides. J. Nutr. 138:1141–1147.
179. Schouten, B., Van Esch, B.C., Kormelink, T.G., Moro, G.E., Arslanoglu, S., Boehm, G., Knippels, L.M., Redegeld, F.A., Willemsen, L.E. and Garssen, J. (2011). Non-digestible oligosaccharides reduce immunoglobulin free light-chain concentrations in infants at risk for allergy. Pediatr. Allergy Immunol. 22:537–542.
180. Schouten, B., van Esch, B.C., Hofman, G.A., van Doorn, S.A., Knol, J., Nauta, A.J., Garssen, J., Willemsen, L.E. and Knippels, L.M. (2009). Cow milk allergy symptoms are reduced in mice fed dietary synbiotics during oral sensitization with whey. J. Nutr. 139:1398–1403.
181. Schultz, M., Munro, K., Tannock, G.W., Melchner, I., Gottl, C., Schwietz, H., Scholmerich, J. and Rath, H.C. (2004). Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats. Clin. Diagn Lab. Immunol. 11:581–587.
182. Seidel, C., Boehm, V., Vogelsang, H., Wagner, A., Persin, C., Glei, M., Pool-Zobel, B.L. and Jahreis, G. (2007). Influence of prebiotics and antioxidants in bread on the immune system, antioxidative status and antioxidative capacity in male smokers and non-smokers. Br. J. Nutr. 97:349–356.
183. Seifert, S. and Watzl, B. (2007). Inulin and oligofructose: Review of experimental data on immune modulation. J. Nutr. 137:2563S–2567S.
184. Sembries, S., Dongowski, G., Jacobasch, G., Mehrlander, K., Will, F. and Dietrich, H. (2003). Effects of dietary fibre-rich juice colloids from apple pomace extraction juices on intestinal fermentation products and microbiota in rats. Br. J. Nutr. 90:607–615.
185. Shadid, R., Haarman, M., Knol, J., Theis, W., Beermann, C., Rjosk-Dendorfer, D., Schendel, D.J., Koletzko, B.V. and Krauss-Etschmann, S. (2007). Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity–a randomized, double-blind, placebo-controlled study. Am. J. Clin. Nutr. 86:1426–1437.
186. Shim, S.B., Verstegen, M.W., Kim, I.H., Kwon, O.S. and Verdonk, J.M. (2005). Effects of feeding antibiotic-free creep feed supplemented with oligofructose, probiotics or synbiotics to suckling piglets increases the preweaning weight gain and composition of intestinal microbiota. Arch. Anim. Nutr. 59:419–427.
187. Smith, C.L., Geier, M.S., Yazbeck, R., Torres, D.M., Butler, R.N. and Howarth, G.S. (2008). Lactobacillus fermentum BR11 and fructo-oligosaccharide partially reduce jejunal inflammation in a model of intestinal mucositis in rats. Nutr. Cancer. 60:757–767.
188. Spahn, T.W. and Kucharzik, T. (2004). Modulating the intestinal immune system: The role of lymphotoxin and GALT organs. Gut. 53:456–465.
189. Spiller, R.C., Jenkins, D., Thornley, J.P., Hebden, J.M., Wright, T., Skinner, M. and Neal, K.R. (2000). Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 47:804–811.
190. Stewart, M.L., Timm, D.A. and Slavin, J.L. (2008). Fructooligosaccharides exhibit more rapid fermentation than long-chain inulin in an in vitro fermentation system. Nutr. Res. 28:329–334.
191. Stillie, R., Bell, R.C. and Field, C.J. (2005). Diabetes-prone BioBreeding rats do not have a normal immune response when weaned to a diet containing fermentable fibre. Br. J. Nutr. 93:645–653.
192. Strober, W., Fuss, I. and Mannon, P. (2007). The fundamental basis of inflammatory bowel disease. J. Clin. Invest. 117:514–521.
193. Swanson, K.S., Grieshop, C.M., Flickinger, E.A., Healy, H.P., Dawson, K.A., Merchen, N.R. and Fahey, G.C., Jr. (2002). Effects of supplemental fructooligosaccharides plus mannanoligosaccharides on immune function and ileal and fecal microbial populations in adult dogs. Arch. Tierernahr. 56:309–318.
194. Taper, H.S., Delzenne, N.M. and Roberfroid, M.B. (1997). Growth inhibition of transplantable mouse tumors by non-digestible carbohydrates. Int. J. Cancer. 71:1109–1112.
195. Taper, H.S., Lemort, C. and Roberfroid, M.B. (1998). Inhibition effect of dietary inulin and oligofructose on the growth of transplantable mouse tumor. Anticancer. Res. 18:4123–4126.
196. Taper, H.S. and Roberfroid, M. (1999). Influence of inulin and oligofructose on breast cancer and tumor growth. J. Nutr. 129:1488S91S
197. Taper, H.S. and Roberfroid, M.B. (2000a). Inhibitory effect of dietary inulin or oligofructose on the development of cancer metastases. Anticancer. Res. 20:4291–4294.
198. Taper, H.S. and Roberfroid, M.B. (2000b). Nontoxic potentiation of cancer chemotherapy by dietary oligofructose or inulin. Nutr. Cancer. 38:1–5.
199. Taper, H.S. and Roberfroid, M.B. (2002). Non-toxic potentiation of cancer radiotherapy by dietary oligofructose or inulin. Anticancer. Res. 22:3319–3323.
200. Taper, H.S. and Roberfroid, M.B. (2005). Possible adjuvant cancer therapy by two prebiotics–inulin or oligofructose. In Vivo. 19:201–204.
201. Thomsen, L.E., Petkevicius, S., Bach Knudsen, K.E. and Roepstorff, A. (2005). The influence of dietary carbohydrates on experimental infection with Trichuris suis in pigs. Parasitology. 131:857–865.
202. Tornblom, H., Lindberg, G., Nyberg, B. and Veress, B. (2002). Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology. 123:1972–1979.
203. Travis, S. (2006). Review article: Saving the colon in severe colitis - the case for medical therapy. Aliment Pharmacol Ther. 24(Suppl 3):68–73.
204. Trifari, S., Kaplan, C.D., Tran, E.H., Crellin, N.K. and Spits, H. (2009). Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat. Immunol. 10:864–871.
205. Trushina, E.N., Martynova, E.A., Nikitiuk, D.B., Mustafina, O.K. and Baigarin, E.K. (2005). The influence of dietary inulin and oligofructose on the cell-mediated and humoral immunity in rats. Vopr. Pitan. 74:22–27.
206. van der Horst, H.E., Jellema, P., van der Windt, D.A. and Schellevis, F.G. (2010). Irritable bowel syndrome: Criteria and clinical view. Ned. Tijdschr. Geneeskd. 154:A1871.
207. van de Wiele, T., Boon, N., Possemiers, S., Jacobs, H. and Verstraete, W. (2007). Inulin-type fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects. J. Appl. Microbiol. 102:452–460.
208. van Hoffen, E., Ruiter, B., Faber, J., M’Rabet, L., Knol, E.F., Stahl, B., Arslanoglu, S., Moro, G., Boehm, G. and Garssen, J. (2009). A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy. Allergy. 64:484–487.
209. Veldhoen, M., Uyttenhove, C., van Snick, J., Helmby, H., Westendorf, A., Buer, J., Martin, B., Wilhelm, C. and Stockinger, B. (2008). Transforming growth factor-beta ‘reprograms’ the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9:1341–1346.
210. Vereyken, I.J., Chupin, V., Hoekstra, F.A., Smeekens, S.C. and de Kruijff, B. (2003a). The effect of fructan on membrane lipid organization and dynamics in the dry state. Biophys. J. 84:3759–3766.
211. Vereyken, I.J., Chupin, V., Islamov, A., Kuklin, A., Hincha, D.K. and de Kruijff, B. (2003b). The effect of fructan on the phospholipid organization in the dry state. Biophys. J. 85:3058–3065.
212. Vereyken, I.J., van Kuik, J.A., Evers, T.H., Rijken, P.J. and de Kruijff, B. (2003c). Structural requirements of the fructan-lipid interaction. Biophys. J. 84:3147–3154.
213. Verghese, M., Rao, D.R., Chawan, C.B. and Shackelford, L. (2002a). Dietary inulin suppresses azoxymethane-induced preneoplastic aberrant crypt foci in mature Fisher 344 rats. J. Nutr. 132:2804–2808.
214. Verghese, M., Rao, D.R., Chawan, C.B., Williams, L.L. and Shackelford, L. (2002b). Dietary inulin suppresses azoxymethane-induced aberrant crypt foci and colon tumors at the promotion stage in young Fisher 344 rats. J. Nutr. 132:2809–2813.
215. Verlinden, A., Hesta, M., Hermans, J.M. and Janssens, G.P. (2006). The effects of inulin supplementation of diets with or without hydrolysed protein sources on digestibility, faecal characteristics, haematology and immunoglobulins in dogs. Br. J. Nutr. 96:936–944.
216. Videla, S., Vilaseca, J., Antolin, M., Garcia-Lafuente, A., Guarner, F., Crespo, E., Casalots, J., Salas, A. and Malagelada, J.R. (2001). Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat. Am. J. Gastroenterol. 96:1486–1493.
217. Vos, A.P., Haarman, M., Buco, A., Govers, M., Knol, J., Garssen, J., Stahl, B., Boehm, G. and M’Rabet, L. (2006). A specific prebiotic oligosaccharide mixture stimulates delayed-type hypersensitivity in a murine influenza vaccination model. Int. Immunopharmacol. 6:1277–1286.
218. Vos, A.P., Haarman, M., van Ginkel, J.W., Knol, J., Garssen, J., Stahl, B., Boehm, G. and M’Rabet, L. (2007a). Dietary supplementation of neutral and acidic oligosaccharides enhances Th1-dependent vaccination responses in mice. Pediatr. Allergy Immunol. 18:304–312.
219. Vos, A.P., M’Rabet, L., Stahl, B., Boehm, G. and Garssen, J. (2007b). Immune-modulatory effects and potential working mechanisms of orally applied nondigestible carbohydrates. Crit. Rev. Immunol. 27:97–140.
220. Vulevic, J., Drakoularakou, A., Yaqoob, P., Tzortzis, G. and Gibson, G.R. (2008). Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am. J. Clin. Nutr. 88:1438–1446.
221. Waligora-Dupriet, A.J., Campeotto, F., Nicolis, I., Bonet, A., Soulaines, P., Dupont, C. and Butel, M.J. (2007). Effect of oligofructose supplementation on gut microflora and well-being in young children attending a day care centre. Int. J. Food Microbiol. 113:108–113.
222. Welters, C.F., Heineman, E., Thunnissen, F.B., van den Bogaard, A.E., Soeters, P.B. and Baeten, C.G. (2002). Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis. Dis. Colon. Rectum. 45:621–627.
223. Whelan, K. (2011). Probiotics and prebiotics in the management of irritable bowel syndrome: A review of recent clinical trials and systematic reviews. Curr. Opin. Clin. Nutr. Metab Care. 14:581–587.
224. Winkler, J., Butler, R. and Symonds, E. (2007). Fructo-oligosaccharide reduces inflammation in a dextran sodium sulphate mouse model of colitis. Dig. Dis. Sci. 52:52–58.
225. Wong, J.M., de Souza, R., Kendall, C.W., Emam, A. and Jenkins, D.J. (2006). Colonic health: Fermentation and short chain fatty acids. J. Clin. Gastroenterol. 40:235–243.
226. Wouters, M.M. and Boeckxstaens, G.E. (2011). Neuroimmune mechanisms in functional bowel disorders. Neth. J. Med. 69:55–61.
227. Wu, G.D., Wang, W. and Traber, P.G. (1992). Isolation and characterization of the human sucrase-isomaltase gene and demonstration of intestine-specific transcriptional elements. J. Biol. Chem. 267:7863–7870.
228. Xavier, R.J. and Podolsky, D.K. (2007). Unravelling the pathogenesis of inflammatory bowel disease. Nature. 448:427–434.
229. Yasuda, K., Dawson, H. D., Wasmuth, E. V., Roneker, C. A., Chen, C., Urban, J. F., Welch, R. M., Miller, D. D., and Lei, X. G. (2009). Supplemental dietary inulin influences expression of iron and inflammation related genes in young pigs. J Nutr. 77:937–942.
230. Yeh, S.L., Lin, M.S. and Chen, H.L. (2007). Inhibitory effects of a soluble dietary fiber from Amorphophallus konjac on cytotoxicity and DNA damage induced by fecal water in Caco-2 cells. Planta. Med. 73:1384–1388.